October 23, 2017 | JAMA Neurology

Comprehension of an Elevated Amyloid Positron Emission Tomography Biomarker Result by Cognitively Normal Older Adults

Advances in understanding the pathophysiology of Alzheimer disease (AD), together with a US national plan to discover interventions to prevent AD by 2025, have led to clinical trials examining treatment in people at risk for development of the disease before they have disabling cognitive impairments.

Loading tweets...